Predicate |
Object |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-76 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-92 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-56 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-565 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-21 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-505 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-577 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-56983 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-1018 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-577 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-569 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-42 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-13 |
filingDate |
2019-01-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate |
2022-03-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate |
2022-03-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
CN-111434685-B |
titleOfInvention |
Fully human monoclonal antibody 9I17 for resisting H7N9, and preparation method and application thereof |
abstract |
The invention relates to an anti-H7N 9 fully human monoclonal antibody 9I17, a preparation method and application thereof. The fully human monoclonal antibody 9I17 is rapidly screened by a memory B cell PCR method and does not contain any murine components. The antibody can be combined with hemagglutinin HA of H7N9 virus in a targeted mode, and HAs the neutralizing activity of obviously resisting H7N9 virus infection; the antibody of the invention does not generate toxic and side effects such as anti-mouse anti-antibody and the like, has better biocompatibility, and is more suitable and has more potential to become a macromolecular drug for treating influenza virus. |
priorityDate |
2019-01-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |